Role of the Growth Suppressor p27Kip1 During Vascular Remodeling
Author(s) -
Antonio Dı́ez-Juan,
Claudia Castro,
Masataka Edo,
Vicente Andrés
Publication year - 2003
Publication title -
current vascular pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.806
H-Index - 60
eISSN - 1875-6212
pISSN - 1570-1611
DOI - 10.2174/1570161033386709
Subject(s) - restenosis , neovascularization , medicine , cell growth , vascular disease , angioplasty , arteriosclerosis , in vivo , cancer research , angiogenesis , in vitro , microbiology and biotechnology , pathology , biology , biochemistry , stent , genetics
At homeostasis, vascular cells display a very low proliferative rate and a scant migratory activity. However, hyperplastic growth and locomotion of vascular cells are a hallmark of vascular remodeling during several pathophysiological conditions (e.g., neovascularization, arteriosclerosis and restenosis post-angioplasty). Thus, a better understanding of the molecular mechanisms that control vascular cell proliferation and migration should facilitate the development of novel therapies to treat cardiovascular disease. In this review, we will discuss recent studies implicating the cell cycle regulatory protein p27Kip1 as a key modulator of vascular cell growth and locomotion in vitro and during vascular remodeling in vivo.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom